We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Saturday
May 16
09:00 - 10:00
A6
Improving outcomes in advanced disease
Bartosz Sobocki, Poland;
Nicola Dinapoli, Italy
Mini-Orals
Clinical
09:00 - 10:00
Impact of radiotherapy dose escalation on survival in lung and oesophageal cancers: a PROSPERO-registered systematic review and meta-analysis
Ahmed Salem, Jordan
-3405
09:00 - 10:00
Efficacy and safety of immune checkpoint inhibitors with high-dose RT in metastatic cancer: a systematic review and meta-analysis of randomized trials
Syed Farooq, Canada
-4988
09:00 - 10:00
Phase I Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided Adaptive Reirradiation for Abdominal and Pelvic Tumors
Michael Chuong, USA
-3359
09:00 - 10:00
COMPARISON OF TARGET VOLUME DEFINITION CONCEPTS IN SBRT FOR VERTEBRAL METASTASES: A SECONDARY ANALYSIS OF TWO PROSPECTIVE CLINICAL TRIALS
Indira Madani, Switzerland
-2642
09:00 - 10:00
Impact of image guidance and dose on local control of patients with liver oligometastases within Momentum and OligoCare studies
Julia Peltenburg, The Netherlands
-3779
09:00 - 10:00
Re-irradiation with proton therapy: quality of life in patients enrolled in the power registry at the European Institute of Oncology
Martina Benincasa, Italy
-3907
09:00 - 10:00
Risk Factors for Vertebral Fracture Following Spine Stereotactic Radiosurgery in Lung Cancer: A Pooled Post Hoc Analysis of Two Phase II Trials
Feng-Ming Hsu, Taiwan, Province of China
-4434
09:00 - 10:00
Safety and Efficacy of SBRT for Atypical Oligometastatic locations: Interim Analysis of the International ESTRO EORTC E2R OligoCare cohort
Esmee Lauren Looman, Switzerland
-2505